LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | 2.0 | 8.0 | 622.0 | 226.0 | - | - | - | 858 |
1 | - | - | - | - | - | 2.0 | 1.0 | - | - | - | 3 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 433.0 |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 796 |
1 | 234 |
Number of post synapses: 858
Number of pre synapses: 3
Number of output connections: 9
Coverage factor: 1.0
Columnar completeness: 0.23
Area completeness: 0.57
Cell size (columns): 204
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVPaMe2 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe5 (R) | ACh | 212 | 212.0 | 14.5% | 14.5% |
1 | aMe30 (R) | Glu | 162 | 162.0 | 11.1% | 25.6% |
2 | MeTu3b (R) | ACh | 132 | 132.0 | 9.0% | 34.7% |
3 | Mi15 (R) | ACh | 111 | 111.0 | 7.6% | 42.3% |
4 | MeVC20 (R) | Glu | 110 | 110.0 | 7.5% | 49.8% |
5 | Mi10 (R) | ACh | 101 | 101.0 | 6.9% | 56.7% |
6 | aMe10 (L) | ACh | 91 | 91.0 | 6.2% | 62.9% |
7 | Cm20 (R) | GABA | 87 | 87.0 | 6.0% | 68.9% |
8 | aMe6b (R) | ACh | 55 | 55.0 | 3.8% | 72.7% |
9 | MeTu1 (R) | ACh | 45 | 45.0 | 3.1% | 75.8% |
10 | Cm11d (R) | ACh | 44 | 44.0 | 3.0% | 78.8% |
11 | aMe12 (R) | ACh | 26 | 26.0 | 1.8% | 80.5% |
12 | aMe26 (R) | ACh | 22 | 22.0 | 1.5% | 82.1% |
13 | Cm-DRA (R) | ACh | 16 | 16.0 | 1.1% | 83.2% |
14 | MeTu3a (R) | ACh | 16 | 16.0 | 1.1% | 84.2% |
15 | MeVP5 (R) | unclear | 14 | 14.0 | 1.0% | 85.2% |
16 | aMe10 (R) | ACh | 11 | 11.0 | 0.8% | 86.0% |
17 | aMe4 (R) | ACh | 11 | 11.0 | 0.8% | 86.7% |
18 | aMe6c (R) | Glu | 11 | 11.0 | 0.8% | 87.5% |
19 | Cm3 (R) | GABA | 11 | 11.0 | 0.8% | 88.2% |
20 | Cm30 (R) | GABA | 10 | 10.0 | 0.7% | 88.9% |
21 | Dm2 (R) | ACh | 10 | 10.0 | 0.7% | 89.6% |
22 | MeVPMe11 (L) | Glu | 10 | 10.0 | 0.7% | 90.3% |
23 | Cm31a (R) | GABA | 9 | 9.0 | 0.6% | 90.9% |
24 | Cm12 (R) | GABA | 8 | 8.0 | 0.5% | 91.4% |
25 | MeVP31 (R) | ACh | 7 | 7.0 | 0.5% | 91.9% |
26 | Cm14 (R) | GABA | 6 | 6.0 | 0.4% | 92.3% |
27 | MeLo6 (R) | ACh | 6 | 6.0 | 0.4% | 92.7% |
28 | MeVP12 (R) | ACh | 6 | 6.0 | 0.4% | 93.2% |
29 | MeVP9 (R) | ACh | 6 | 6.0 | 0.4% | 93.6% |
30 | Cm31b (R) | GABA | 5 | 5.0 | 0.3% | 93.9% |
31 | MeLo3b (R) | ACh | 5 | 5.0 | 0.3% | 94.2% |
32 | Cm9 (R) | Glu | 4 | 4.0 | 0.3% | 94.5% |
33 | Dm-DRA1 (R) | Glu | 4 | 4.0 | 0.3% | 94.8% |
34 | MeVP1 (R) | ACh | 4 | 4.0 | 0.3% | 95.1% |
35 | MeVP7 (R) | ACh | 4 | 4.0 | 0.3% | 95.3% |
36 | aMe15 (R) | unclear | 3 | 3.0 | 0.2% | 95.5% |
37 | aMe22 (R) | Glu | 3 | 3.0 | 0.2% | 95.8% |
38 | aMe24 (R) | unclear | 3 | 3.0 | 0.2% | 96.0% |
39 | Lat3 (R) | unclear | 3 | 3.0 | 0.2% | 96.2% |
40 | MeVP15 (R) | ACh | 3 | 3.0 | 0.2% | 96.4% |
41 | OA-AL2i3 (R) | OA | 3 | 3.0 | 0.2% | 96.6% |
42 | aMe17b (R) | GABA | 2 | 2.0 | 0.1% | 96.7% |
43 | aMe9 (R) | ACh | 2 | 2.0 | 0.1% | 96.8% |
44 | Cm25 (R) | Glu | 2 | 2.0 | 0.1% | 97.0% |
45 | HBeyelet (R) | His | 2 | 2.0 | 0.1% | 97.1% |
46 | MeTu2a (R) | ACh | 2 | 2.0 | 0.1% | 97.3% |
47 | MeTu3c (R) | ACh | 2 | 2.0 | 0.1% | 97.4% |
48 | MeVP28 (R) | ACh | 2 | 2.0 | 0.1% | 97.5% |
49 | MeVPLo2 (R) | ACh | 2 | 2.0 | 0.1% | 97.7% |
50 | OA-AL2i4 (R) | OA | 2 | 2.0 | 0.1% | 97.8% |
51 | TmY18 (R) | ACh | 2 | 2.0 | 0.1% | 97.9% |
52 | aMe12 (L) | ACh | 1 | 1.0 | 0.1% | 98.0% |
53 | aMe17c (R) | Glu | 1 | 1.0 | 0.1% | 98.1% |
54 | aMe2 (R) | Glu | 1 | 1.0 | 0.1% | 98.2% |
55 | aMe9 (L) | ACh | 1 | 1.0 | 0.1% | 98.2% |
56 | Cm18 (R) | Glu | 1 | 1.0 | 0.1% | 98.3% |
57 | Cm28 (R) | unclear | 1 | 1.0 | 0.1% | 98.4% |
58 | Cm33 (R) | GABA | 1 | 1.0 | 0.1% | 98.4% |
59 | Cm8 (R) | GABA | 1 | 1.0 | 0.1% | 98.5% |
60 | Cm_unclear (R) | ACh | 1 | 1.0 | 0.1% | 98.6% |
61 | Lawf1 (R) | ACh | 1 | 1.0 | 0.1% | 98.6% |
62 | MeLo1 (R) | ACh | 1 | 1.0 | 0.1% | 98.7% |
63 | MeLo5 (R) | ACh | 1 | 1.0 | 0.1% | 98.8% |
64 | MeVC22 (R) | Glu | 1 | 1.0 | 0.1% | 98.8% |
65 | MeVC24 (R) | Glu | 1 | 1.0 | 0.1% | 98.9% |
66 | MeVP14 (R) | ACh | 1 | 1.0 | 0.1% | 99.0% |
67 | MeVP22 (R) | GABA | 1 | 1.0 | 0.1% | 99.0% |
68 | MeVP3 (R) | ACh | 1 | 1.0 | 0.1% | 99.1% |
69 | MeVP33 (R) | ACh | 1 | 1.0 | 0.1% | 99.2% |
70 | MeVP39 (R) | unclear | 1 | 1.0 | 0.1% | 99.2% |
71 | MeVP48 (R) | unclear | 1 | 1.0 | 0.1% | 99.3% |
72 | MeVP56 (R) | unclear | 1 | 1.0 | 0.1% | 99.4% |
73 | MeVPMe12 (L) | ACh | 1 | 1.0 | 0.1% | 99.5% |
74 | MeVPMe2 (R) | Glu | 1 | 1.0 | 0.1% | 99.5% |
75 | MeVPMe4 (L) | Glu | 1 | 1.0 | 0.1% | 99.6% |
76 | MeVPMe9 (L) | Glu | 1 | 1.0 | 0.1% | 99.7% |
77 | R7d (R) | His | 1 | 1.0 | 0.1% | 99.7% |
78 | Tm1 (R) | ACh | 1 | 1.0 | 0.1% | 99.8% |
79 | Tm39 (R) | ACh | 1 | 1.0 | 0.1% | 99.9% |
80 | Tm5c (R) | Glu | 1 | 1.0 | 0.1% | 99.9% |
81 | Tm_unclear (R) | GABA | 1 | 1.0 | 0.1% | 100.0% |
instance | NT | total connections | connections /#MeVPaMe2 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe17c (R) | Glu | 2 | 2.0 | 13.3% | 13.3% |
1 | aMe4 (R) | ACh | 2 | 2.0 | 13.3% | 26.7% |
2 | aMe30 (R) | Glu | 1 | 1.0 | 6.7% | 33.3% |
3 | Cm11d (R) | ACh | 1 | 1.0 | 6.7% | 40.0% |
4 | Cm14 (R) | GABA | 1 | 1.0 | 6.7% | 46.7% |
5 | Cm30 (R) | GABA | 1 | 1.0 | 6.7% | 53.3% |
6 | Lat3 (R) | unclear | 1 | 1.0 | 6.7% | 60.0% |
7 | MeTu3b (R) | ACh | 1 | 1.0 | 6.7% | 66.7% |
8 | MeVC3 (L) | ACh | 1 | 1.0 | 6.7% | 73.3% |
9 | MeVP49 (R) | unclear | 1 | 1.0 | 6.7% | 80.0% |
10 | MeVP56 (R) | unclear | 1 | 1.0 | 6.7% | 86.7% |
11 | MeVPMe12 (R) | ACh | 1 | 1.0 | 6.7% | 93.3% |
12 | Mi19 (R) | 5HT | 1 | 1.0 | 6.7% | 100.0% |